MANNKIND CORP Increase (Decrease) in Customer Advances and Deposits
MANNKIND CORP (MNKD) reported Increase (Decrease) in Customer Advances and Deposits of $11.98 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › ASU 2014-09 Transition
us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits · last filed 2018-11-01
- MANNKIND CORP increase (decrease) in customer advances and deposits for the quarter ending 2018-09-30 was $9.93M.
- MANNKIND CORP increase (decrease) in customer advances and deposits for the quarter ending 2018-06-30 was $2.11M.
- MANNKIND CORP increase (decrease) in customer advances and deposits for the quarter ending 2018-03-31 was -$63.00K.
- MANNKIND CORP increase (decrease) in customer advances and deposits for the quarter ending 2017-12-31 was -$63.00K, a 106.30% decline year-over-year.
- MANNKIND CORP increase (decrease) in customer advances and deposits for fiscal 2017 was -$250.00K.
- MANNKIND CORP increase (decrease) in customer advances and deposits for fiscal 2016 was -$134.06M, a 14211.16% decline from fiscal 2015.
- MANNKIND CORP increase (decrease) in customer advances and deposits for fiscal 2015 was $950.00K, a 99.53% decline from fiscal 2014.
- MANNKIND CORP increase (decrease) in customer advances and deposits for fiscal 2014 was $200.44M.
| Period end | Increase (Decrease) in Customer Advances and Deposits 3 month | Increase (Decrease) in Customer Advances and Deposits 6 month | Increase (Decrease) in Customer Advances and Deposits 6 month as first filed | Increase (Decrease) in Customer Advances and Deposits 9 month | Increase (Decrease) in Customer Advances and Deposits 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | $9.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $12.05M derived: sum of 2 quarters · filed 2018-11-01 | $11.98M 10-Q · filed 2018-11-01 | $11.92M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2018-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.05M 10-Q · filed 2018-08-02 | $1.99M derived: sum of 3 quarters · filed 2018-08-02 | $1.92M derived: sum of 4 quarters · filed 2018-11-01 | |
| 2018-03-31 | -$63.00K 10-Q · filed 2018-05-09 | -$126.00K derived: sum of 2 quarters · filed 2018-05-09 | -$188.00K derived: sum of 3 quarters · filed 2018-11-01 | -$250.00K derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$125.00K derived: sum of 2 quarters · filed 2018-11-01 | -$187.00K derived: sum of 3 quarters · filed 2018-11-01 | -$250.00K 10-K · filed 2018-02-27 | |
| 2017-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$124.00K derived: sum of 2 quarters · filed 2018-11-01 | -$187.00K 10-Q · filed 2018-11-01 | $813.00K derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | -$62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$125.00K 10-Q · filed 2018-08-02 | $875.00K derived: sum of 3 quarters · filed 2018-08-02 | -$143.56M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | -$63.00K 10-Q · filed 2018-05-09 | $937.00K derived: sum of 2 quarters · filed 2018-05-09 | -$143.50M derived: sum of 3 quarters · filed 2018-05-09 | -$134.30M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$143.44M derived: sum of 2 quarters · filed 2018-02-27 | -$134.23M derived: sum of 3 quarters · filed 2018-02-27 | -$134.06M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$144.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$135.23M derived: sum of 2 quarters · filed 2017-11-07 | -$135.06M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $9.38M 10-Q · filed 2017-08-07 | $9.20M 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | $177.00K 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $950.00K 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $50.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $200.44M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $150.00M 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |